What is the appropriate praziquantel dose for hepatic schistosomiasis, including in patients with moderate to severe hepatic impairment and children older than 2 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Praziquantel Dosing for Hepatic Schistosomiasis

For hepatic schistosomiasis, administer praziquantel 40 mg/kg orally as a single dose for S. mansoni, S. intercalatum, and S. guineensis infections, or 60 mg/kg orally divided into two doses on the same day for S. japonicum and S. mekongi infections, with a mandatory repeat dose at 6-8 weeks regardless of species. 1, 2

Species-Specific Dosing Algorithm

Step 1: Identify the Schistosoma species

  • For S. mansoni, S. haematobium, S. intercalatum, or S. guineensis: Administer 40 mg/kg as a single oral dose with food 1, 2, 3
  • For S. japonicum or S. mekongi: Administer 60 mg/kg divided into two doses on the same day (e.g., 30 mg/kg twice daily, 4-6 hours apart) 1, 2
  • For serology-diagnosed infections from Asia-Pacific region (species uncertain): Use the higher 60 mg/kg regimen divided into two doses to ensure adequate coverage 1, 2

Step 2: Schedule mandatory follow-up dosing

  • Repeat the same dose at 6-8 weeks post-initial treatment, as immature schistosomules are relatively resistant to praziquantel and may survive the first treatment 2
  • This two-dose strategy (initial + 6-8 week repeat) is essential for treatment success regardless of species 2

Pediatric Dosing (Children >2 Years)

Use the same mg/kg dosing as adults, with practical tablet-splitting strategies based on weight: 4

  • 5-7 kg: ½ tablet (300 mg)
  • 8-10 kg: ¾ tablet (450 mg)
  • 11-15 kg: 1 tablet (600 mg)
  • 16-21 kg: 1½ tablets (900 mg)
  • 22-25 kg: 2 tablets (1200 mg)

This weight-based splitting achieves 40-60 mg/kg dosing in 100% of children when using 600 mg tablets that can be divided into quarters (150 mg increments) 4. For children weighing ≥10 kg, tablets divisible into halves (300 mg) are adequate 4.

Hepatic Impairment Considerations

Critical finding: Despite altered pharmacokinetics in hepatic dysfunction, standard 40 mg/kg dosing remains effective and should not be reduced 5

  • In patients with liver cirrhosis and varying degrees of hepatocellular dysfunction (Child's classification groups), praziquantel half-life, maximum concentration, and area under the curve increase proportionally with hepatic insufficiency severity 5
  • However, cure rates were paradoxically higher in patients with more severe liver disease (70% in simple schistosomiasis vs. 90% in advanced cirrhosis with ascites/jaundice) 5
  • Do not reduce the dose in hepatic impairment—maintain 40 mg/kg as a single dose 5
  • Side effects (53% incidence) were transient and mild despite elevated drug levels 5

Key caveat: The only hepatic-related dosing adjustment applies to rimantadine (an influenza drug), not praziquantel—do not confuse these medications 1

Administration Guidelines

  • Always administer with food to optimize absorption 3
  • Avoid concurrent dexamethasone, which reduces praziquantel levels through increased hepatic metabolism 2, 3
  • If corticosteroids are necessary (e.g., for acute Katayama syndrome), use prednisolone instead of dexamethasone 2, 3

Special Clinical Scenarios

Acute Schistosomiasis (Katayama Syndrome)

  • Administer prednisolone 20-30 mg daily for 5 days first to reduce inflammatory symptoms 2
  • Give praziquantel 40 mg/kg after the acute inflammatory phase subsides 2
  • Repeat praziquantel at 6-8 weeks as immature parasites survive initial treatment 2

Neuroschistosomiasis

  • Increase to praziquantel 40 mg/kg twice daily for 5 consecutive days (total 400 mg/kg over 5 days) 2
  • Combine with dexamethasone 4 mg four times daily, tapering after 7 days, for total 2-6 weeks 2
  • In acute neuroschistosomiasis, give corticosteroids before anthelmintic therapy 2

Monitoring and Treatment Failure

  • Do not use serology to assess treatment success—antibodies persist for years after cure 1, 2
  • If viable eggs persist after completing both doses (initial + 6-8 week repeat), consider true treatment failure 2
  • For documented treatment failure, seek specialist advice rather than repeating standard dosing; consider combination therapy with artemisinin derivatives 2

Common Pitfalls to Avoid

  • Failing to adjust for species: S. japonicum and S. mekongi require 60 mg/kg (not 40 mg/kg) to achieve adequate cure rates 1, 2
  • Omitting the 6-8 week repeat dose: This is mandatory for all species, not optional 2
  • Reducing dose in liver disease: Maintain standard 40 mg/kg despite cirrhosis or hepatic dysfunction 5
  • Using dexamethasone with praziquantel: This drug interaction significantly reduces praziquantel efficacy 2, 3
  • Starting corticosteroids without ruling out strongyloidiasis: Screen for Strongyloides before giving steroids to prevent hyperinfection syndrome 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bilharzia (Schistosomiasis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Praziquantel Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Practical dosing of praziquantel for schistosomiasis in preschool-aged children.

Tropical medicine & international health : TM & IH, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.